 | • レポートコード：QFJ1-4524 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、125ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査レポートでは、がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（薬理ゲノミクス診断、リキッドバイオプシー、その他）、用途別市場規模（呼吸器がん、消化器がん、泌尿器がん、循環がん、運動がん、生殖器がん、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・がん分子診断の市場動向 ・企業の競争状況、市場シェア ・がん分子診断の種類別市場規模と予測2016-2027（薬理ゲノミクス診断、リキッドバイオプシー、その他） ・がん分子診断の用途別市場規模と予測2016-2027（呼吸器がん、消化器がん、泌尿器がん、循環がん、運動がん、生殖器がん、その他） ・がん分子診断の北米市場規模2016-2027（アメリカ、カナダ） ・がん分子診断の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・がん分子診断のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・がん分子診断の中南米市場規模2016-2027（メキシコ、ブラジル） ・がん分子診断の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Roche、Danaher、Siemens、Abbott Laboratories、ICON Plc、AstraZeneca、MDxHealth、Invitae、PlexBio、Thermo Fisher Scientific、Guardant Health、Biocartis、Bio-Techne、Merck、Foundation Medicine、10X Genomics、Biodesix、CytoTrack、GenomOncology、Luminex） ・結論 |
A cancer molecular diagnosis is a laboratory test that examines certain genes, proteins, or other molecules in a sample of tissue, blood, or other body fluids.It also examines certain changes in genes or chromosomes that may cause or affect the chances of developing cancer.To help diagnose certain types of cancer.It can also be used to help plan treatment and find out treatment effects or prognosis.
Market Analysis and Insights: Global Molecular Diagnostics Cancer Market
The global Molecular Diagnostics Cancer market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Molecular Diagnostics Cancer market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Molecular Diagnostics Cancer market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Molecular Diagnostics Cancer market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Molecular Diagnostics Cancer market.
Global Molecular Diagnostics Cancer Scope and Market Size
Molecular Diagnostics Cancer market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Molecular Diagnostics Cancer market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Pharmacogenomic Diagnosis
Liquid Biopsy
Other
Segment by Application
Respiratory Cancer
Cancer of Digestive System
Cancer of Urinary System
Cancer of Circulatory System
Motor System Cancer
Reproductive System Cancer
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Roche
Danaher
Siemens
Abbott Laboratories
ICON Plc
AstraZeneca
MDxHealth
Invitae
PlexBio
Thermo Fisher Scientific
Guardant Health
Biocartis
Bio-Techne
Merck
Foundation Medicine
10X Genomics
Biodesix
CytoTrack
GenomOncology
Luminex
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Molecular Diagnostics Cancer Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Pharmacogenomic Diagnosis
1.2.3 Liquid Biopsy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Molecular Diagnostics Cancer Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Respiratory Cancer
1.3.3 Cancer of Digestive System
1.3.4 Cancer of Urinary System
1.3.5 Cancer of Circulatory System
1.3.6 Motor System Cancer
1.3.7 Reproductive System Cancer
1.3.8 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Molecular Diagnostics Cancer Market Perspective (2016-2027)
2.2 Molecular Diagnostics Cancer Growth Trends by Regions
2.2.1 Molecular Diagnostics Cancer Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Molecular Diagnostics Cancer Historic Market Share by Regions (2016-2021)
2.2.3 Molecular Diagnostics Cancer Forecasted Market Size by Regions (2022-2027)
2.3 Molecular Diagnostics Cancer Industry Dynamic
2.3.1 Molecular Diagnostics Cancer Market Trends
2.3.2 Molecular Diagnostics Cancer Market Drivers
2.3.3 Molecular Diagnostics Cancer Market Challenges
2.3.4 Molecular Diagnostics Cancer Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Molecular Diagnostics Cancer Players by Revenue
3.1.1 Global Top Molecular Diagnostics Cancer Players by Revenue (2016-2021)
3.1.2 Global Molecular Diagnostics Cancer Revenue Market Share by Players (2016-2021)
3.2 Global Molecular Diagnostics Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Molecular Diagnostics Cancer Revenue
3.4 Global Molecular Diagnostics Cancer Market Concentration Ratio
3.4.1 Global Molecular Diagnostics Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Molecular Diagnostics Cancer Revenue in 2020
3.5 Molecular Diagnostics Cancer Key Players Head office and Area Served
3.6 Key Players Molecular Diagnostics Cancer Product Solution and Service
3.7 Date of Enter into Molecular Diagnostics Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Molecular Diagnostics Cancer Breakdown Data by Type
4.1 Global Molecular Diagnostics Cancer Historic Market Size by Type (2016-2021)
4.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2022-2027)
5 Molecular Diagnostics Cancer Breakdown Data by Application
5.1 Global Molecular Diagnostics Cancer Historic Market Size by Application (2016-2021)
5.2 Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Molecular Diagnostics Cancer Market Size (2016-2027)
6.2 North America Molecular Diagnostics Cancer Market Size by Type
6.2.1 North America Molecular Diagnostics Cancer Market Size by Type (2016-2021)
6.2.2 North America Molecular Diagnostics Cancer Market Size by Type (2022-2027)
6.2.3 North America Molecular Diagnostics Cancer Market Size by Type (2016-2027)
6.3 North America Molecular Diagnostics Cancer Market Size by Application
6.3.1 North America Molecular Diagnostics Cancer Market Size by Application (2016-2021)
6.3.2 North America Molecular Diagnostics Cancer Market Size by Application (2022-2027)
6.3.3 North America Molecular Diagnostics Cancer Market Size by Application (2016-2027)
6.4 North America Molecular Diagnostics Cancer Market Size by Country
6.4.1 North America Molecular Diagnostics Cancer Market Size by Country (2016-2021)
6.4.2 North America Molecular Diagnostics Cancer Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Molecular Diagnostics Cancer Market Size (2016-2027)
7.2 Europe Molecular Diagnostics Cancer Market Size by Type
7.2.1 Europe Molecular Diagnostics Cancer Market Size by Type (2016-2021)
7.2.2 Europe Molecular Diagnostics Cancer Market Size by Type (2022-2027)
7.2.3 Europe Molecular Diagnostics Cancer Market Size by Type (2016-2027)
7.3 Europe Molecular Diagnostics Cancer Market Size by Application
7.3.1 Europe Molecular Diagnostics Cancer Market Size by Application (2016-2021)
7.3.2 Europe Molecular Diagnostics Cancer Market Size by Application (2022-2027)
7.3.3 Europe Molecular Diagnostics Cancer Market Size by Application (2016-2027)
7.4 Europe Molecular Diagnostics Cancer Market Size by Country
7.4.1 Europe Molecular Diagnostics Cancer Market Size by Country (2016-2021)
7.4.2 Europe Molecular Diagnostics Cancer Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Molecular Diagnostics Cancer Market Size (2016-2027)
8.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type
8.2.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2016-2027)
8.3 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application
8.3.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2016-2027)
8.4 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region
8.4.1 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Molecular Diagnostics Cancer Market Size (2016-2027)
9.2 Latin America Molecular Diagnostics Cancer Market Size by Type
9.2.1 Latin America Molecular Diagnostics Cancer Market Size by Type (2016-2021)
9.2.2 Latin America Molecular Diagnostics Cancer Market Size by Type (2022-2027)
9.2.3 Latin America Molecular Diagnostics Cancer Market Size by Type (2016-2027)
9.3 Latin America Molecular Diagnostics Cancer Market Size by Application
9.3.1 Latin America Molecular Diagnostics Cancer Market Size by Application (2016-2021)
9.3.2 Latin America Molecular Diagnostics Cancer Market Size by Application (2022-2027)
9.3.3 Latin America Molecular Diagnostics Cancer Market Size by Application (2016-2027)
9.4 Latin America Molecular Diagnostics Cancer Market Size by Country
9.4.1 Latin America Molecular Diagnostics Cancer Market Size by Country (2016-2021)
9.4.2 Latin America Molecular Diagnostics Cancer Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Molecular Diagnostics Cancer Market Size (2016-2027)
10.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type
10.2.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2016-2027)
10.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application
10.3.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2016-2027)
10.4 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country
10.4.1 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Molecular Diagnostics Cancer Introduction
11.1.4 Roche Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.1.5 Roche Recent Development
11.2 Danaher
11.2.1 Danaher Company Details
11.2.2 Danaher Business Overview
11.2.3 Danaher Molecular Diagnostics Cancer Introduction
11.2.4 Danaher Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.2.5 Danaher Recent Development
11.3 Siemens
11.3.1 Siemens Company Details
11.3.2 Siemens Business Overview
11.3.3 Siemens Molecular Diagnostics Cancer Introduction
11.3.4 Siemens Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.3.5 Siemens Recent Development
11.4 Abbott Laboratories
11.4.1 Abbott Laboratories Company Details
11.4.2 Abbott Laboratories Business Overview
11.4.3 Abbott Laboratories Molecular Diagnostics Cancer Introduction
11.4.4 Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.4.5 Abbott Laboratories Recent Development
11.5 ICON Plc
11.5.1 ICON Plc Company Details
11.5.2 ICON Plc Business Overview
11.5.3 ICON Plc Molecular Diagnostics Cancer Introduction
11.5.4 ICON Plc Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.5.5 ICON Plc Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Molecular Diagnostics Cancer Introduction
11.6.4 AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.6.5 AstraZeneca Recent Development
11.7 MDxHealth
11.7.1 MDxHealth Company Details
11.7.2 MDxHealth Business Overview
11.7.3 MDxHealth Molecular Diagnostics Cancer Introduction
11.7.4 MDxHealth Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.7.5 MDxHealth Recent Development
11.8 Invitae
11.8.1 Invitae Company Details
11.8.2 Invitae Business Overview
11.8.3 Invitae Molecular Diagnostics Cancer Introduction
11.8.4 Invitae Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.8.5 Invitae Recent Development
11.9 PlexBio
11.9.1 PlexBio Company Details
11.9.2 PlexBio Business Overview
11.9.3 PlexBio Molecular Diagnostics Cancer Introduction
11.9.4 PlexBio Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.9.5 PlexBio Recent Development
11.10 Thermo Fisher Scientific
11.10.1 Thermo Fisher Scientific Company Details
11.10.2 Thermo Fisher Scientific Business Overview
11.10.3 Thermo Fisher Scientific Molecular Diagnostics Cancer Introduction
11.10.4 Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.10.5 Thermo Fisher Scientific Recent Development
11.11 Guardant Health
11.11.1 Guardant Health Company Details
11.11.2 Guardant Health Business Overview
11.11.3 Guardant Health Molecular Diagnostics Cancer Introduction
11.11.4 Guardant Health Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.11.5 Guardant Health Recent Development
11.12 Biocartis
11.12.1 Biocartis Company Details
11.12.2 Biocartis Business Overview
11.12.3 Biocartis Molecular Diagnostics Cancer Introduction
11.12.4 Biocartis Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.12.5 Biocartis Recent Development
11.13 Bio-Techne
11.13.1 Bio-Techne Company Details
11.13.2 Bio-Techne Business Overview
11.13.3 Bio-Techne Molecular Diagnostics Cancer Introduction
11.13.4 Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.13.5 Bio-Techne Recent Development
11.14 Merck
11.14.1 Merck Company Details
11.14.2 Merck Business Overview
11.14.3 Merck Molecular Diagnostics Cancer Introduction
11.14.4 Merck Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.14.5 Merck Recent Development
11.15 Foundation Medicine
11.15.1 Foundation Medicine Company Details
11.15.2 Foundation Medicine Business Overview
11.15.3 Foundation Medicine Molecular Diagnostics Cancer Introduction
11.15.4 Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.15.5 Foundation Medicine Recent Development
11.16 10X Genomics
11.16.1 10X Genomics Company Details
11.16.2 10X Genomics Business Overview
11.16.3 10X Genomics Molecular Diagnostics Cancer Introduction
11.16.4 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.16.5 10X Genomics Recent Development
11.17 Biodesix
11.17.1 Biodesix Company Details
11.17.2 Biodesix Business Overview
11.17.3 Biodesix Molecular Diagnostics Cancer Introduction
11.17.4 Biodesix Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.17.5 Biodesix Recent Development
11.18 CytoTrack
11.18.1 CytoTrack Company Details
11.18.2 CytoTrack Business Overview
11.18.3 CytoTrack Molecular Diagnostics Cancer Introduction
11.18.4 CytoTrack Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.18.5 CytoTrack Recent Development
11.18 GenomOncology
.1 GenomOncology Company Details
.2 GenomOncology Business Overview
.3 GenomOncology Molecular Diagnostics Cancer Introduction
.4 GenomOncology Revenue in Molecular Diagnostics Cancer Business (2016-2021)
.5 GenomOncology Recent Development
11.20 Luminex
11.20.1 Luminex Company Details
11.20.2 Luminex Business Overview
11.20.3 Luminex Molecular Diagnostics Cancer Introduction
11.20.4 Luminex Revenue in Molecular Diagnostics Cancer Business (2016-2021)
11.20.5 Luminex Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Molecular Diagnostics Cancer Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Pharmacogenomic Diagnosis
Table 3. Key Players of Liquid Biopsy
Table 4. Key Players of Other
Table 5. Global Molecular Diagnostics Cancer Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Molecular Diagnostics Cancer Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Molecular Diagnostics Cancer Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Molecular Diagnostics Cancer Market Share by Regions (2016-2021)
Table 9. Global Molecular Diagnostics Cancer Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Molecular Diagnostics Cancer Market Share by Regions (2022-2027)
Table 11. Molecular Diagnostics Cancer Market Trends
Table 12. Molecular Diagnostics Cancer Market Drivers
Table 13. Molecular Diagnostics Cancer Market Challenges
Table 14. Molecular Diagnostics Cancer Market Restraints
Table 15. Global Molecular Diagnostics Cancer Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Molecular Diagnostics Cancer Market Share by Players (2016-2021)
Table 17. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics Cancer as of 2020)
Table 18. Ranking of Global Top Molecular Diagnostics Cancer Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Molecular Diagnostics Cancer Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Molecular Diagnostics Cancer Product Solution and Service
Table 22. Date of Enter into Molecular Diagnostics Cancer Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Molecular Diagnostics Cancer Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2016-2021)
Table 26. Global Molecular Diagnostics Cancer Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Molecular Diagnostics Cancer Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Molecular Diagnostics Cancer Revenue Market Share by Application (2016-2021)
Table 30. Global Molecular Diagnostics Cancer Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Molecular Diagnostics Cancer Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Molecular Diagnostics Cancer Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Molecular Diagnostics Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Molecular Diagnostics Cancer Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Molecular Diagnostics Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Molecular Diagnostics Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Molecular Diagnostics Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Molecular Diagnostics Cancer Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Molecular Diagnostics Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Molecular Diagnostics Cancer Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Molecular Diagnostics Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Molecular Diagnostics Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Molecular Diagnostics Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Molecular Diagnostics Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Molecular Diagnostics Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Molecular Diagnostics Cancer Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Molecular Diagnostics Cancer Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Molecular Diagnostics Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Molecular Diagnostics Cancer Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Molecular Diagnostics Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Molecular Diagnostics Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Molecular Diagnostics Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Molecular Diagnostics Cancer Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Molecular Diagnostics Cancer Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Molecular Diagnostics Cancer Market Size by Country (2022-2027) & (US$ Million)
Table 62. Roche Company Details
Table 63. Roche Business Overview
Table 64. Roche Molecular Diagnostics Cancer Product
Table 65. Roche Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 66. Roche Recent Development
Table 67. Danaher Company Details
Table 68. Danaher Business Overview
Table 69. Danaher Molecular Diagnostics Cancer Product
Table 70. Danaher Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 71. Danaher Recent Development
Table 72. Siemens Company Details
Table 73. Siemens Business Overview
Table 74. Siemens Molecular Diagnostics Cancer Product
Table 75. Siemens Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 76. Siemens Recent Development
Table 77. Abbott Laboratories Company Details
Table 78. Abbott Laboratories Business Overview
Table 79. Abbott Laboratories Molecular Diagnostics Cancer Product
Table 80. Abbott Laboratories Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 81. Abbott Laboratories Recent Development
Table 82. ICON Plc Company Details
Table 83. ICON Plc Business Overview
Table 84. ICON Plc Molecular Diagnostics Cancer Product
Table 85. ICON Plc Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 86. ICON Plc Recent Development
Table 87. AstraZeneca Company Details
Table 88. AstraZeneca Business Overview
Table 89. AstraZeneca Molecular Diagnostics Cancer Product
Table 90. AstraZeneca Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 91. AstraZeneca Recent Development
Table 92. MDxHealth Company Details
Table 93. MDxHealth Business Overview
Table 94. MDxHealth Molecular Diagnostics Cancer Product
Table 95. MDxHealth Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 96. MDxHealth Recent Development
Table 97. Invitae Company Details
Table 98. Invitae Business Overview
Table 99. Invitae Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 100. Invitae Recent Development
Table 101. PlexBio Company Details
Table 102. PlexBio Business Overview
Table 103. PlexBio Molecular Diagnostics Cancer Product
Table 104. PlexBio Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 105. PlexBio Recent Development
Table 106. Thermo Fisher Scientific Company Details
Table 107. Thermo Fisher Scientific Business Overview
Table 108. Thermo Fisher Scientific Molecular Diagnostics Cancer Product
Table 109. Thermo Fisher Scientific Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 110. Thermo Fisher Scientific Recent Development
Table 111. Guardant Health Company Details
Table 112. Guardant Health Business Overview
Table 113. Guardant Health Molecular Diagnostics Cancer Product
Table 114. Guardant Health Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 115. Guardant Health Recent Development
Table 116. Biocartis Company Details
Table 117. Biocartis Business Overview
Table 118. Biocartis Molecular Diagnostics Cancer Product
Table 119. Biocartis Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 120. Biocartis Recent Development
Table 121. Bio-Techne Company Details
Table 122. Bio-Techne Business Overview
Table 123. Bio-Techne Molecular Diagnostics Cancer Product
Table 124. Bio-Techne Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 125. Bio-Techne Recent Development
Table 126. Merck Company Details
Table 127. Merck Business Overview
Table 128. Merck Molecular Diagnostics Cancer Product
Table 129. Merck Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 130. Merck Recent Development
Table 131. Foundation Medicine Company Details
Table 132. Foundation Medicine Business Overview
Table 133. Foundation Medicine Molecular Diagnostics Cancer Product
Table 134. Foundation Medicine Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 135. Foundation Medicine Recent Development
Table 136. 10X Genomics Company Details
Table 137. 10X Genomics Business Overview
Table 138. 10X Genomics Molecular Diagnostics Cancer Product
Table 139. 10X Genomics Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 140. 10X Genomics Recent Development
Table 141. Biodesix Company Details
Table 142. Biodesix Business Overview
Table 143. Biodesix Molecular Diagnostics Cancer Product
Table 144. Biodesix Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 145. Biodesix Recent Development
Table 146. CytoTrack Company Details
Table 147. CytoTrack Business Overview
Table 148. CytoTrack Molecular Diagnostics Cancer Product
Table 149. CytoTrack Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 150. CytoTrack Recent Development
Table 151. GenomOncology Company Details
Table 152. GenomOncology Business Overview
Table 153. GenomOncology Molecular Diagnostics Cancer Product
Table 154. GenomOncology Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 155. GenomOncology Recent Development
Table 156. Luminex Company Details
Table 157. Luminex Business Overview
Table 158. Luminex Molecular Diagnostics Cancer Product
Table 159. Luminex Revenue in Molecular Diagnostics Cancer Business (2016-2021) & (US$ Million)
Table 160. Luminex Recent Development
Table 161. Research Programs/Design for This Report
Table 162. Key Data Information from Secondary Sources
Table 163. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Molecular Diagnostics Cancer Market Share by Type: 2020 VS 2027
Figure 2. Pharmacogenomic Diagnosis Features
Figure 3. Liquid Biopsy Features
Figure 4. Other Features
Figure 5. Global Molecular Diagnostics Cancer Market Share by Application: 2020 VS 2027
Figure 6. Respiratory Cancer Case Studies
Figure 7. Cancer of Digestive System Case Studies
Figure 8. Cancer of Urinary System Case Studies
Figure 9. Cancer of Circulatory System Case Studies
Figure 10. Motor System Cancer Case Studies
Figure 11. Reproductive System Cancer Case Studies
Figure 12. Other Case Studies
Figure 13. Molecular Diagnostics Cancer Report Years Considered
Figure 14. Global Molecular Diagnostics Cancer Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 15. Global Molecular Diagnostics Cancer Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Molecular Diagnostics Cancer Market Share by Regions: 2020 VS 2027
Figure 17. Global Molecular Diagnostics Cancer Market Share by Regions (2022-2027)
Figure 18. Global Molecular Diagnostics Cancer Market Share by Players in 2020
Figure 19. Global Top Molecular Diagnostics Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Molecular Diagnostics Cancer as of 2020
Figure 20. The Top 10 and 5 Players Market Share by Molecular Diagnostics Cancer Revenue in 2020
Figure 21. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2016-2021)
Figure 22. Global Molecular Diagnostics Cancer Revenue Market Share by Type (2022-2027)
Figure 23. North America Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. North America Molecular Diagnostics Cancer Market Share by Type (2016-2027)
Figure 25. North America Molecular Diagnostics Cancer Market Share by Application (2016-2027)
Figure 26. North America Molecular Diagnostics Cancer Market Share by Country (2016-2027)
Figure 27. United States Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Canada Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. Europe Molecular Diagnostics Cancer Market Share by Type (2016-2027)
Figure 31. Europe Molecular Diagnostics Cancer Market Share by Application (2016-2027)
Figure 32. Europe Molecular Diagnostics Cancer Market Share by Country (2016-2027)
Figure 33. Germany Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. France Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. U.K. Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Italy Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Russia Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Nordic Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Asia-Pacific Molecular Diagnostics Cancer Market Share by Type (2016-2027)
Figure 41. Asia-Pacific Molecular Diagnostics Cancer Market Share by Application (2016-2027)
Figure 42. Asia-Pacific Molecular Diagnostics Cancer Market Share by Region (2016-2027)
Figure 43. China Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Japan Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. South Korea Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Southeast Asia Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. India Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Australia Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Latin America Molecular Diagnostics Cancer Market Share by Type (2016-2027)
Figure 51. Latin America Molecular Diagnostics Cancer Market Share by Application (2016-2027)
Figure 52. Latin America Molecular Diagnostics Cancer Market Share by Country (2016-2027)
Figure 53. Mexico Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Brazil Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Middle East & Africa Molecular Diagnostics Cancer Market Share by Type (2016-2027)
Figure 57. Middle East & Africa Molecular Diagnostics Cancer Market Share by Application (2016-2027)
Figure 58. Middle East & Africa Molecular Diagnostics Cancer Market Share by Country (2016-2027)
Figure 59. Turkey Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Saudi Arabia Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. UAE Molecular Diagnostics Cancer Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 62. Roche Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 63. Danaher Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 64. Siemens Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 65. Abbott Laboratories Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 66. ICON Plc Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 68. MDxHealth Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 69. Invitae Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 70. PlexBio Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 71. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 72. Guardant Health Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 73. Biocartis Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 74. Bio-Techne Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 75. Merck Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 76. Foundation Medicine Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 77. 10X Genomics Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 78. Biodesix Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 79. CytoTrack Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 80. GenomOncology Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 81. Luminex Revenue Growth Rate in Molecular Diagnostics Cancer Business (2016-2021)
Figure 82. Bottom-up and Top-down Approaches for This Report
Figure 83. Data Triangulation
Figure 84. Key Executives Interviewed
世界の皮膚がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing skin cancer Market Analysis and Insights: Global Skin Cancer Molecular Diagnostics Market The global Skin Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With in…- 世界の喉頭がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing laryngeal cancer Market Analysis and Insights: Global Laryngeal Cancer Molecular Diagnostics Market The global Laryngeal Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 202…
- 世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing oral cancer Market Analysis and Insights: Global Oral Cancer Molecular Diagnosis Market The global Oral Cancer Molecular Diagnosis market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With indust…
- 世界の膵臓がん分子診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing pancreatic cancer Market Analysis and Insights: Global Pancreatic Cancer Molecular Diagnostics Market The global Pancreatic Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during …
- 世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing bladder cancer Market Analysis and Insights: Global Bladder Cancer Molecular Diagnostics Market The global Bladder Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…